Abiomed Inc (NASDAQ:ABMD)

Data as of Oct 21
 +0.42 / +1.78%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

ABIOMED, Inc. develops, manufactures and markets advanced medical technologies designed to assist or replace the pumping function of the failing heart. The company provides medical devices in circulatory support and offers a continuum of care in heart recovery to acute heart failure patients. It develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and performing the pumping function of the heart. The company's products are used in the cardiac catheterization lab, or cath lab, by interventional cardiologists and in the heart surgery. ABIOMED was founded in 1981 and is headquartered in Danvers, MA.

Contact Information

22 Cherry Hill Drive
Danvers Massachusetts 01923
P:(978) 646-1400
Investor Relations:



Other institutional61.08%
Mutual fund holders49.03%
Individual stakeholders20.72%

Top Executives

Michael R. MinogueChairman, President & Chief Executive Officer
David M. WeberChief Operating Officer
Robert L. BowenChief Financial Officer, Treasurer, CAO & VP
Karim BenaliChief Medical Officer
Thorsten SiessChief Technology Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.